Protalix BioTherapeutics Reports Fiscal Year 2015 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. DFTX
8. LCO
9. KR
10. MSTR

Go back to Protalix BioTherapeutics Reports Fiscal Year 2015 Financial Results and Provides Corporate Update

Protalix BioTherapeutics (PLX) Reports Q4 Loss of $0.29/Share

March 8, 2016 7:35 AM EST

Protalix BioTherapeutics (NYSE: PLX) reported Q4 EPS of ($0.29), versus ($0.36) reported last year. Revenue for the quarter came in at $4.4 million, versus $3.5 million reported last year.

For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.

... More